HIGH

Biofire Defense Recalls FilmArray NGDS Warrior Panel Due to Control Failures

Biofire Defense recalled 130 kits of the FilmArray NGDS Warrior Panel on July 10, 2025. The recall is due to an increased risk of internal control failures when testing positive blood cultures. These failures could delay results and require additional diagnostic workups.

Quick Facts at a Glance

Recall Date
July 10, 2025
Hazard Level
HIGH
Brand
Biofire Defense
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

FilmArray NGDS Warrior Panel (NGDS-ASY-0007) has an increased risk of internal control failures when testing positive blood culture, which may lead to delayed results and additional diagnostic workup.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Biofire Defense or your healthcare provider for instructions. Notification method: Letter

Product Details

The FilmArray NGDS Warrior Panel (NGDS-ASY-0007) is a multiplexed, nucleic acid-based diagnostic test designed for use with the FilmArray 2.0 system. It is classified as a Class II medical device and has been distributed nationwide across multiple states.

The Hazard

There is an increased risk of internal control failures when using the FilmArray NGDS Warrior Panel for positive blood culture testing. This may lead to delays in diagnosis and treatment.

Reported Incidents

Currently, there are no specific incident reports or injury counts related to this recall, but the potential for delayed diagnosis poses a significant health risk.

What to Do

Patients and healthcare providers should stop using the FilmArray NGDS Warrior Panel immediately. Follow the recall instructions provided by Biofire Defense and contact your healthcare provider for further guidance.

Contact Information

For more information, contact Biofire Defense or visit the recall notice at the FDA's website: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2609-2025.

Key Facts

  • 130 kits recalled
  • Increased risk of control failures
  • Stop using the product immediately
  • Follow recall instructions
  • Contact Biofire Defense for guidance

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeIn Vitro Diagnostic Test
Sold At
Multiple Retailers

Product Details

Model Numbers
UDI-DI: 00851458005136
Lot(Expiration): 324324D(2026-02-19)
D241022(2026-01-22)
319524D(2025-11-20)
315424D(2025-10-09)
+2 more
Affected States
ALL
Report Date
October 1, 2025
Source Agency
FDA - Medical Devices
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more